These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 541694)

  • 1. Thyroid-hormone concentrations after radioiodine therapy for hyperthyroidism.
    Tamagna EI; Levine GA; Hershman JM
    J Nucl Med; 1979 May; 20(5):387-91. PubMed ID: 541694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
    Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G
    Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical study on early changes in thyroid function of hyperthyroidism treated with propylthiouracil and a relatively small dose of iodide.
    Kasai K; Suzuki H; Kikuchi T; Ieiri T; Takemura Y
    Endocrinol Jpn; 1976 Aug; 23(4):347-54. PubMed ID: 1024041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between serum triiodothyronine and thyroxine concentrations in hyperthyroidism.
    de Rave S; Bravenboer B; Loosveld OJ; Lockefeer JH; Goldschmidt HM
    Neth J Med; 1993 Feb; 42(1-2):48-52. PubMed ID: 8446224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum T4, T3 and reverse T3 during treatment with propranolol in hyperthyroidism, L-T4 treated myxedema and in normal man.
    Faber J; Friis T; Kirkegaard C; Lumholtz IB; Hansen JM; Siersbaek-Nielsen K; Skovsted L; Theilade P
    Horm Metab Res; 1979 Jan; 11(1):34-6. PubMed ID: 428906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
    Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated high serum triiodothyronine levels. Clinical relevance after sodium iodide I 131 therapy.
    Soler NG; Kennedy W; Wortsman J
    Arch Intern Med; 1979 Jan; 139(1):36-8. PubMed ID: 760681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of various contraceptives on laboratory parameters in diagnosis of thyroid gland function with special reference to the free hormones FT4 and FT3].
    Sorger D; Schenk S; Schneider G
    Z Gesamte Inn Med; 1992 Feb; 47(2):58-64. PubMed ID: 1585690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT).
    Czarnywojtek A; Czepczynski R; Ruchala M; Wasko R; Zgorzalewicz-Stachowiak M; Szczepanek E; Zamyslowska H; Bartkowiak Z; Florek E; Sowinski J
    Neuro Endocrinol Lett; 2009; 30(2):209-14. PubMed ID: 19675515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioiodine treatment of hyperthyroidism in a pregnant women.
    Berg GE; Nyström EH; Jacobsson L; Lindberg S; Lindstedt RG; Mattsson S; Niklasson CA; Norén AH; Westphal OG
    J Nucl Med; 1998 Feb; 39(2):357-61. PubMed ID: 9476950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and management of large toxic multinodular goiters.
    Hamburger JI; Hamburger SW
    J Nucl Med; 1985 Aug; 26(8):888-92. PubMed ID: 2411889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of additional inactive iodide during radioiodine therapy for Graves' disease: who might benefit?
    Dietlein M; Moka D; Reinholz U; Schmidt M; Schomäcker K; Schicha H; Wellner U
    Nuklearmedizin; 2007; 46(3):77-84. PubMed ID: 17549318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease and toxic multinodular goiter.
    Gedik O; Ozdemir T; Akalin S
    Isr J Med Sci; 1991 Jul; 27(7):361-4. PubMed ID: 1712765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictor of outcome of hyperthyroidism due to Graves disease: serum triiodothyronine/thyroxine ratio.
    Khanna CM; Shankar LR; Jaggi CB; Bansal JK; Chugh P
    J Assoc Physicians India; 1996 Feb; 44(2):98-101. PubMed ID: 10999059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
    Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum thyroxine and triiodothyronine responses of hyperthyroid cats to thyrotropin.
    Mooney CT; Thoday KL; Doxey DL
    Am J Vet Res; 1996 Jul; 57(7):987-91. PubMed ID: 8807008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of thyroid hormone-induced metabolic conditions using the T4 and T3 tests with reference to radioiodine therapy].
    Grebe SF
    Radiologe; 1974 Apr; 14(4):161-5. PubMed ID: 4134611
    [No Abstract]   [Full Text] [Related]  

  • 18. Radioiodine therapy in hyperthyroid disease: poorer outcome in patients with high 24 hours radioiodine uptake.
    Kristoffersen US; Hesse B; Rasmussen AK; Kjaer A
    Clin Physiol Funct Imaging; 2006 May; 26(3):167-70. PubMed ID: 16640512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.